Organization Profile

You just read:

Synageva BioPharma™ Reports Positive Top-Line Results From Phase 3 Study Of Sebelipase Alfa In Children And Adults With LAL Deficiency

News provided by

Synageva BioPharma Corp.

Jun 30, 2014, 16:02 ET